Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation.

Dennis PB, Fumagalli S, Thomas G.

Curr Opin Genet Dev. 1999 Feb;9(1):49-54. Review.

PMID:
10072357
2.

Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.

Crespo JL, Hall MN.

Microbiol Mol Biol Rev. 2002 Dec;66(4):579-91, table of contents. Review.

3.
4.

The target of rapamycin (TOR) proteins.

Raught B, Gingras AC, Sonenberg N.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7037-44. Review.

5.

Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.

Alarcon CM, Cardenas ME, Heitman J.

Genes Dev. 1996 Feb 1;10(3):279-88.

6.
7.

Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin.

Oldham S, Montagne J, Radimerski T, Thomas G, Hafen E.

Genes Dev. 2000 Nov 1;14(21):2689-94.

8.

TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.

Zheng XF, Florentino D, Chen J, Crabtree GR, Schreiber SL.

Cell. 1995 Jul 14;82(1):121-30.

9.

Regulation of the cell integrity pathway by rapamycin-sensitive TOR function in budding yeast.

Torres J, Di Como CJ, Herrero E, De La Torre-Ruiz MA.

J Biol Chem. 2002 Nov 8;277(45):43495-504. Epub 2002 Aug 8.

10.

Control of translation by the target of rapamycin proteins.

Gingras AC, Raught B, Sonenberg N.

Prog Mol Subcell Biol. 2001;27:143-74. Review. No abstract available.

PMID:
11575159
11.
12.
13.

The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease.

Schmidt A, Beck T, Koller A, Kunz J, Hall MN.

EMBO J. 1998 Dec 1;17(23):6924-31.

14.

Activation of the RAS/cyclic AMP pathway suppresses a TOR deficiency in yeast.

Schmelzle T, Beck T, Martin DE, Hall MN.

Mol Cell Biol. 2004 Jan;24(1):338-51.

15.
16.

TOR modulates GCN4-dependent expression of genes turned on by nitrogen limitation.

Valenzuela L, Aranda C, González A.

J Bacteriol. 2001 Apr;183(7):2331-4.

17.

Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway.

Butcher RA, Bhullar BS, Perlstein EO, Marsischky G, LaBaer J, Schreiber SL.

Nat Chem Biol. 2006 Feb;2(2):103-9. Epub 2006 Jan 15.

PMID:
16415861
18.

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A, Hall MN.

Nat Cell Biol. 2004 Nov;6(11):1122-8. Epub 2004 Oct 3.

PMID:
15467718
19.
20.

The 14-3-3 proteins positively regulate rapamycin-sensitive signaling.

Bertram PG, Zeng C, Thorson J, Shaw AS, Zheng XF.

Curr Biol. 1998 Nov 19;8(23):1259-67.

Supplemental Content

Support Center